Pain Management Drugs
Pain Management Drugs

Pain Management Drugs Comprehensive Study by Type (Generic Opioids, Branded Opioids), Application (Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain, Others), Distribution Channel (Hospitals, Clinics, Drugstores), Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic analgesics, Opioids) Players and Region - Global Market Outlook to 2026

Pain Management Drugs Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2021 Edition 207 Pages 173 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Pain Management Drugs Market Overview:
Pain is complex, so there are many treatment options medications, therapies, and mind-body techniques. Pain management can be easy or complex, depending on the cause of the pain. An example of pain that is typically less complex would be nerve root irritation from a herniated disc with pain radiating down the leg. This situation can often be alleviated with an epidural steroid injection and physical therapy. Sometimes, still, the pain does not go away which requires a wide variety of skills and techniques to treat the pain. The pain management drugs help in treating various painful conditions. Some of the players profiled in the study are Pfizer (United States), GSK (United Kingdom), Grunenthal (Germany), Bayer (Germany), Sanofi (France), Eli Lilly (United States), AstraZeneca (United Kingdom), Endo (Ireland), Merck (United States) and Depomed (United States).

On the basis of geography, the market of Pain Management Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Hospitals will boost the Pain Management Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Drug Class , the sub-segment i.e. Anesthetics will boost the Pain Management Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers
  • Increasing Demand for Long-Term Pain Management among the Geriatric Population
  • Adverse Effects of Pain Medicines
  • High Proven Effectiveness of Pain Management Drugs for the Treatment of Chronic Pain

Influencing Trend
  • Consumption of Over-The-Counter (OTC) Drugs Rather Than Prescription Drugs Among Patients
  • Development of New Pain Management Drugs

Restraints
  • Low Awareness about the Use of Pain Management Drugs
  • Dearth of Pain Specialists and Low Number of Pain Clinics in Several Countries

Opportunities
  • High Growth in Number of Patients Suffering From Neuropathic Pain
  • Strict Regulations to Limit Opioid Pain Killer Prescriptions

Challenges
  • Availability of Alternative Therapies for Pain Management




The market is fragmented by both small and big players who have locked horns with each other in the market and are making tireless efforts to gain supremacy over their counterparts. This cut-throat competition is expected to prove beneficial for the consumers who will now have a wide range of vendors, each of whom is willing to go an extra mile to attract the consumers. The strategy that can help these players in growing their customer base and expansion of their product portfolio.

Target Audience:
Manufacturers of Pain Management Drugs, Suppliers of Pain Management Drugs, Wholesalers, Distributors, and Retailers of Pain Management Drugs, Healthcare Industry, Governmental Bodies and Research Firms

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Pain Management Drugs market on the basis of product [Generic Opioids and Branded Opioids] , application [Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain and Others], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Pain Management Drugs market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Pain Management Drugs industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Yunnan Baiyao, Teva, J&J, Allergan and Purdue.
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Pain Management Drugs market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Report Objectives / Segmentation Covered
By Type
  • Generic Opioids
  • Branded Opioids
By Application
  • Burn Pain
  • Cancer Pain
  • Dental/Facial Pain
  • Migraine Headache Pain
  • Musculoskeletal Pain
  • Neuropathic Pain
  • Obstetrical Pain
  • Others
By Distribution Channel
  • Hospitals
  • Clinics
  • Drugstores

By Drug Class
  • Anesthetics
  • NSAIDS
  • Anticonvulsants
  • Antidepressants
  • Anti-migraine agents
  • Non-narcotic analgesics
  • Opioids

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Long-Term Pain Management among the Geriatric Population
      • 3.2.2. Adverse Effects of Pain Medicines
      • 3.2.3. High Proven Effectiveness of Pain Management Drugs for the Treatment of Chronic Pain
    • 3.3. Market Challenges
      • 3.3.1. Availability of Alternative Therapies for Pain Management
    • 3.4. Market Trends
      • 3.4.1. Consumption of Over-The-Counter (OTC) Drugs Rather Than Prescription Drugs Among Patients
      • 3.4.2. Development of New Pain Management Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pain Management Drugs, by Type, Application, Distribution Channel, Drug Class and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pain Management Drugs (Value)
      • 5.2.1. Global Pain Management Drugs by: Type (Value)
        • 5.2.1.1. Generic Opioids
        • 5.2.1.2. Branded Opioids
      • 5.2.2. Global Pain Management Drugs by: Application (Value)
        • 5.2.2.1. Burn Pain
        • 5.2.2.2. Cancer Pain
        • 5.2.2.3. Dental/Facial Pain
        • 5.2.2.4. Migraine Headache Pain
        • 5.2.2.5. Musculoskeletal Pain
        • 5.2.2.6. Neuropathic Pain
        • 5.2.2.7. Obstetrical Pain
        • 5.2.2.8. Others
      • 5.2.3. Global Pain Management Drugs by: Distribution Channel (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Drugstores
      • 5.2.4. Global Pain Management Drugs Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pain Management Drugs (Volume)
      • 5.3.1. Global Pain Management Drugs by: Type (Volume)
        • 5.3.1.1. Generic Opioids
        • 5.3.1.2. Branded Opioids
      • 5.3.2. Global Pain Management Drugs by: Application (Volume)
        • 5.3.2.1. Burn Pain
        • 5.3.2.2. Cancer Pain
        • 5.3.2.3. Dental/Facial Pain
        • 5.3.2.4. Migraine Headache Pain
        • 5.3.2.5. Musculoskeletal Pain
        • 5.3.2.6. Neuropathic Pain
        • 5.3.2.7. Obstetrical Pain
        • 5.3.2.8. Others
      • 5.3.3. Global Pain Management Drugs by: Distribution Channel (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
        • 5.3.3.3. Drugstores
      • 5.3.4. Global Pain Management Drugs Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Pain Management Drugs (Price)
      • 5.4.1. Global Pain Management Drugs by: Type (Price)
  • 6. Pain Management Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GSK (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Grunenthal (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bayer (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sanofi (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Eli Lilly (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. AstraZeneca (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Endo (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Merck (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Depomed (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pain Management Drugs Sale, by Type, Application, Distribution Channel, Drug Class and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pain Management Drugs (Value)
      • 7.2.1. Global Pain Management Drugs by: Type (Value)
        • 7.2.1.1. Generic Opioids
        • 7.2.1.2. Branded Opioids
      • 7.2.2. Global Pain Management Drugs by: Application (Value)
        • 7.2.2.1. Burn Pain
        • 7.2.2.2. Cancer Pain
        • 7.2.2.3. Dental/Facial Pain
        • 7.2.2.4. Migraine Headache Pain
        • 7.2.2.5. Musculoskeletal Pain
        • 7.2.2.6. Neuropathic Pain
        • 7.2.2.7. Obstetrical Pain
        • 7.2.2.8. Others
      • 7.2.3. Global Pain Management Drugs by: Distribution Channel (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Drugstores
      • 7.2.4. Global Pain Management Drugs Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pain Management Drugs (Volume)
      • 7.3.1. Global Pain Management Drugs by: Type (Volume)
        • 7.3.1.1. Generic Opioids
        • 7.3.1.2. Branded Opioids
      • 7.3.2. Global Pain Management Drugs by: Application (Volume)
        • 7.3.2.1. Burn Pain
        • 7.3.2.2. Cancer Pain
        • 7.3.2.3. Dental/Facial Pain
        • 7.3.2.4. Migraine Headache Pain
        • 7.3.2.5. Musculoskeletal Pain
        • 7.3.2.6. Neuropathic Pain
        • 7.3.2.7. Obstetrical Pain
        • 7.3.2.8. Others
      • 7.3.3. Global Pain Management Drugs by: Distribution Channel (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
        • 7.3.3.3. Drugstores
      • 7.3.4. Global Pain Management Drugs Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Pain Management Drugs (Price)
      • 7.4.1. Global Pain Management Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pain Management Drugs: by Type(USD Million)
  • Table 2. Pain Management Drugs Generic Opioids , by Region USD Million (2015-2020)
  • Table 3. Pain Management Drugs Branded Opioids , by Region USD Million (2015-2020)
  • Table 4. Pain Management Drugs: by Application(USD Million)
  • Table 5. Pain Management Drugs Burn Pain , by Region USD Million (2015-2020)
  • Table 6. Pain Management Drugs Cancer Pain , by Region USD Million (2015-2020)
  • Table 7. Pain Management Drugs Dental/Facial Pain , by Region USD Million (2015-2020)
  • Table 8. Pain Management Drugs Migraine Headache Pain , by Region USD Million (2015-2020)
  • Table 9. Pain Management Drugs Musculoskeletal Pain , by Region USD Million (2015-2020)
  • Table 10. Pain Management Drugs Neuropathic Pain , by Region USD Million (2015-2020)
  • Table 11. Pain Management Drugs Obstetrical Pain , by Region USD Million (2015-2020)
  • Table 12. Pain Management Drugs Others , by Region USD Million (2015-2020)
  • Table 13. Pain Management Drugs: by Distribution Channel(USD Million)
  • Table 14. Pain Management Drugs Hospitals , by Region USD Million (2015-2020)
  • Table 15. Pain Management Drugs Clinics , by Region USD Million (2015-2020)
  • Table 16. Pain Management Drugs Drugstores , by Region USD Million (2015-2020)
  • Table 17. South America Pain Management Drugs, by Country USD Million (2015-2020)
  • Table 18. South America Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 19. South America Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 20. South America Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 21. South America Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 22. Brazil Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 23. Brazil Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 24. Brazil Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 25. Brazil Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 26. Argentina Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 27. Argentina Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 28. Argentina Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 29. Argentina Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 30. Rest of South America Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 33. Rest of South America Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 34. Asia Pacific Pain Management Drugs, by Country USD Million (2015-2020)
  • Table 35. Asia Pacific Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 36. Asia Pacific Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 37. Asia Pacific Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 38. Asia Pacific Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 39. China Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 40. China Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 41. China Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 42. China Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 43. Japan Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 44. Japan Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 45. Japan Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 46. Japan Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 47. India Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 48. India Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 49. India Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 50. India Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 51. South Korea Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 52. South Korea Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 53. South Korea Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 54. South Korea Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 55. Taiwan Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 56. Taiwan Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 57. Taiwan Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 58. Taiwan Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 59. Australia Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 60. Australia Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 61. Australia Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 62. Australia Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 67. Europe Pain Management Drugs, by Country USD Million (2015-2020)
  • Table 68. Europe Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 69. Europe Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 70. Europe Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 71. Europe Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 72. Germany Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 73. Germany Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 74. Germany Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 75. Germany Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 76. France Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 77. France Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 78. France Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 79. France Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 80. Italy Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 81. Italy Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 82. Italy Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 83. Italy Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 84. United Kingdom Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 85. United Kingdom Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 86. United Kingdom Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 87. United Kingdom Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 88. Netherlands Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 89. Netherlands Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 90. Netherlands Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 91. Netherlands Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 92. Rest of Europe Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 93. Rest of Europe Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 94. Rest of Europe Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 95. Rest of Europe Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 96. MEA Pain Management Drugs, by Country USD Million (2015-2020)
  • Table 97. MEA Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 98. MEA Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 99. MEA Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 100. MEA Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 101. Middle East Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 102. Middle East Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 103. Middle East Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 104. Middle East Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 105. Africa Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 106. Africa Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 107. Africa Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 108. Africa Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 109. North America Pain Management Drugs, by Country USD Million (2015-2020)
  • Table 110. North America Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 111. North America Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 112. North America Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 113. North America Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 114. United States Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 115. United States Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 116. United States Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 117. United States Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 118. Canada Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 119. Canada Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 120. Canada Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 121. Canada Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 122. Mexico Pain Management Drugs, by Type USD Million (2015-2020)
  • Table 123. Mexico Pain Management Drugs, by Application USD Million (2015-2020)
  • Table 124. Mexico Pain Management Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 125. Mexico Pain Management Drugs, by Drug Class USD Million (2015-2020)
  • Table 126. Pain Management Drugs Sales: by Type(K Unit)
  • Table 127. Pain Management Drugs Sales Generic Opioids , by Region K Unit (2015-2020)
  • Table 128. Pain Management Drugs Sales Branded Opioids , by Region K Unit (2015-2020)
  • Table 129. Pain Management Drugs Sales: by Application(K Unit)
  • Table 130. Pain Management Drugs Sales Burn Pain , by Region K Unit (2015-2020)
  • Table 131. Pain Management Drugs Sales Cancer Pain , by Region K Unit (2015-2020)
  • Table 132. Pain Management Drugs Sales Dental/Facial Pain , by Region K Unit (2015-2020)
  • Table 133. Pain Management Drugs Sales Migraine Headache Pain , by Region K Unit (2015-2020)
  • Table 134. Pain Management Drugs Sales Musculoskeletal Pain , by Region K Unit (2015-2020)
  • Table 135. Pain Management Drugs Sales Neuropathic Pain , by Region K Unit (2015-2020)
  • Table 136. Pain Management Drugs Sales Obstetrical Pain , by Region K Unit (2015-2020)
  • Table 137. Pain Management Drugs Sales Others , by Region K Unit (2015-2020)
  • Table 138. Pain Management Drugs Sales: by Distribution Channel(K Unit)
  • Table 139. Pain Management Drugs Sales Hospitals , by Region K Unit (2015-2020)
  • Table 140. Pain Management Drugs Sales Clinics , by Region K Unit (2015-2020)
  • Table 141. Pain Management Drugs Sales Drugstores , by Region K Unit (2015-2020)
  • Table 142. South America Pain Management Drugs Sales, by Country K Unit (2015-2020)
  • Table 143. South America Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 144. South America Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 145. South America Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 146. South America Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 147. Brazil Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 148. Brazil Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 149. Brazil Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 150. Brazil Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 151. Argentina Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 152. Argentina Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 153. Argentina Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 154. Argentina Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 155. Rest of South America Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 156. Rest of South America Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 157. Rest of South America Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 158. Rest of South America Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 159. Asia Pacific Pain Management Drugs Sales, by Country K Unit (2015-2020)
  • Table 160. Asia Pacific Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 161. Asia Pacific Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 162. Asia Pacific Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 163. Asia Pacific Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 164. China Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 165. China Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 166. China Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 167. China Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 168. Japan Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 169. Japan Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 170. Japan Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 171. Japan Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 172. India Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 173. India Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 174. India Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 175. India Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 176. South Korea Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 177. South Korea Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 178. South Korea Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 179. South Korea Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 180. Taiwan Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 181. Taiwan Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 182. Taiwan Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 183. Taiwan Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 184. Australia Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 185. Australia Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 186. Australia Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 187. Australia Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 188. Rest of Asia-Pacific Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 189. Rest of Asia-Pacific Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 190. Rest of Asia-Pacific Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 191. Rest of Asia-Pacific Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 192. Europe Pain Management Drugs Sales, by Country K Unit (2015-2020)
  • Table 193. Europe Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 194. Europe Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 195. Europe Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 196. Europe Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 197. Germany Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 198. Germany Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 199. Germany Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 200. Germany Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 201. France Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 202. France Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 203. France Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 204. France Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 205. Italy Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 206. Italy Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 207. Italy Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 208. Italy Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 209. United Kingdom Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 210. United Kingdom Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 211. United Kingdom Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 212. United Kingdom Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 213. Netherlands Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 214. Netherlands Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 215. Netherlands Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 216. Netherlands Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 217. Rest of Europe Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 218. Rest of Europe Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 219. Rest of Europe Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 220. Rest of Europe Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 221. MEA Pain Management Drugs Sales, by Country K Unit (2015-2020)
  • Table 222. MEA Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 223. MEA Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 224. MEA Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 225. MEA Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 226. Middle East Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 227. Middle East Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 228. Middle East Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 229. Middle East Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 230. Africa Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 231. Africa Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 232. Africa Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 233. Africa Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 234. North America Pain Management Drugs Sales, by Country K Unit (2015-2020)
  • Table 235. North America Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 236. North America Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 237. North America Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 238. North America Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 239. United States Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 240. United States Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 241. United States Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 242. United States Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 243. Canada Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 244. Canada Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 245. Canada Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 246. Canada Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 247. Mexico Pain Management Drugs Sales, by Type K Unit (2015-2020)
  • Table 248. Mexico Pain Management Drugs Sales, by Application K Unit (2015-2020)
  • Table 249. Mexico Pain Management Drugs Sales, by Distribution Channel K Unit (2015-2020)
  • Table 250. Mexico Pain Management Drugs Sales, by Drug Class K Unit (2015-2020)
  • Table 251. Pain Management Drugs: by Type(USD/Units)
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Pain Management Drugs: by Type(USD Million)
  • Table 263. Pain Management Drugs Generic Opioids , by Region USD Million (2021-2026)
  • Table 264. Pain Management Drugs Branded Opioids , by Region USD Million (2021-2026)
  • Table 265. Pain Management Drugs: by Application(USD Million)
  • Table 266. Pain Management Drugs Burn Pain , by Region USD Million (2021-2026)
  • Table 267. Pain Management Drugs Cancer Pain , by Region USD Million (2021-2026)
  • Table 268. Pain Management Drugs Dental/Facial Pain , by Region USD Million (2021-2026)
  • Table 269. Pain Management Drugs Migraine Headache Pain , by Region USD Million (2021-2026)
  • Table 270. Pain Management Drugs Musculoskeletal Pain , by Region USD Million (2021-2026)
  • Table 271. Pain Management Drugs Neuropathic Pain , by Region USD Million (2021-2026)
  • Table 272. Pain Management Drugs Obstetrical Pain , by Region USD Million (2021-2026)
  • Table 273. Pain Management Drugs Others , by Region USD Million (2021-2026)
  • Table 274. Pain Management Drugs: by Distribution Channel(USD Million)
  • Table 275. Pain Management Drugs Hospitals , by Region USD Million (2021-2026)
  • Table 276. Pain Management Drugs Clinics , by Region USD Million (2021-2026)
  • Table 277. Pain Management Drugs Drugstores , by Region USD Million (2021-2026)
  • Table 278. South America Pain Management Drugs, by Country USD Million (2021-2026)
  • Table 279. South America Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 280. South America Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 281. South America Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 282. South America Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 283. Brazil Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 284. Brazil Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 285. Brazil Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 286. Brazil Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 287. Argentina Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 288. Argentina Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 289. Argentina Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 290. Argentina Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 291. Rest of South America Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 292. Rest of South America Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 293. Rest of South America Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 294. Rest of South America Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 295. Asia Pacific Pain Management Drugs, by Country USD Million (2021-2026)
  • Table 296. Asia Pacific Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 297. Asia Pacific Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 298. Asia Pacific Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 299. Asia Pacific Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 300. China Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 301. China Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 302. China Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 303. China Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 304. Japan Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 305. Japan Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 306. Japan Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 307. Japan Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 308. India Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 309. India Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 310. India Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 311. India Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 312. South Korea Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 313. South Korea Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 314. South Korea Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 315. South Korea Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 316. Taiwan Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 317. Taiwan Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 318. Taiwan Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 319. Taiwan Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 320. Australia Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 321. Australia Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 322. Australia Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 323. Australia Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 324. Rest of Asia-Pacific Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 325. Rest of Asia-Pacific Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 326. Rest of Asia-Pacific Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 327. Rest of Asia-Pacific Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 328. Europe Pain Management Drugs, by Country USD Million (2021-2026)
  • Table 329. Europe Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 330. Europe Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 331. Europe Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 332. Europe Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 333. Germany Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 334. Germany Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 335. Germany Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 336. Germany Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 337. France Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 338. France Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 339. France Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 340. France Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 341. Italy Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 342. Italy Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 343. Italy Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 344. Italy Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 345. United Kingdom Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 346. United Kingdom Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 347. United Kingdom Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 348. United Kingdom Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 349. Netherlands Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 350. Netherlands Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 351. Netherlands Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 352. Netherlands Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 353. Rest of Europe Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 354. Rest of Europe Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 355. Rest of Europe Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 356. Rest of Europe Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 357. MEA Pain Management Drugs, by Country USD Million (2021-2026)
  • Table 358. MEA Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 359. MEA Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 360. MEA Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 361. MEA Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 362. Middle East Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 363. Middle East Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 364. Middle East Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 365. Middle East Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 366. Africa Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 367. Africa Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 368. Africa Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 369. Africa Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 370. North America Pain Management Drugs, by Country USD Million (2021-2026)
  • Table 371. North America Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 372. North America Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 373. North America Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 374. North America Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 375. United States Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 376. United States Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 377. United States Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 378. United States Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 379. Canada Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 380. Canada Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 381. Canada Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 382. Canada Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 383. Mexico Pain Management Drugs, by Type USD Million (2021-2026)
  • Table 384. Mexico Pain Management Drugs, by Application USD Million (2021-2026)
  • Table 385. Mexico Pain Management Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 386. Mexico Pain Management Drugs, by Drug Class USD Million (2021-2026)
  • Table 387. Pain Management Drugs Sales: by Type(K Unit)
  • Table 388. Pain Management Drugs Sales Generic Opioids , by Region K Unit (2021-2026)
  • Table 389. Pain Management Drugs Sales Branded Opioids , by Region K Unit (2021-2026)
  • Table 390. Pain Management Drugs Sales: by Application(K Unit)
  • Table 391. Pain Management Drugs Sales Burn Pain , by Region K Unit (2021-2026)
  • Table 392. Pain Management Drugs Sales Cancer Pain , by Region K Unit (2021-2026)
  • Table 393. Pain Management Drugs Sales Dental/Facial Pain , by Region K Unit (2021-2026)
  • Table 394. Pain Management Drugs Sales Migraine Headache Pain , by Region K Unit (2021-2026)
  • Table 395. Pain Management Drugs Sales Musculoskeletal Pain , by Region K Unit (2021-2026)
  • Table 396. Pain Management Drugs Sales Neuropathic Pain , by Region K Unit (2021-2026)
  • Table 397. Pain Management Drugs Sales Obstetrical Pain , by Region K Unit (2021-2026)
  • Table 398. Pain Management Drugs Sales Others , by Region K Unit (2021-2026)
  • Table 399. Pain Management Drugs Sales: by Distribution Channel(K Unit)
  • Table 400. Pain Management Drugs Sales Hospitals , by Region K Unit (2021-2026)
  • Table 401. Pain Management Drugs Sales Clinics , by Region K Unit (2021-2026)
  • Table 402. Pain Management Drugs Sales Drugstores , by Region K Unit (2021-2026)
  • Table 403. South America Pain Management Drugs Sales, by Country K Unit (2021-2026)
  • Table 404. South America Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 405. South America Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 406. South America Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 407. South America Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 408. Brazil Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 409. Brazil Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 410. Brazil Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 411. Brazil Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 412. Argentina Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 413. Argentina Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 414. Argentina Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 415. Argentina Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 416. Rest of South America Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 417. Rest of South America Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 418. Rest of South America Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 419. Rest of South America Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 420. Asia Pacific Pain Management Drugs Sales, by Country K Unit (2021-2026)
  • Table 421. Asia Pacific Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 422. Asia Pacific Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 423. Asia Pacific Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 424. Asia Pacific Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 425. China Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 426. China Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 427. China Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 428. China Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 429. Japan Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 430. Japan Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 431. Japan Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 432. Japan Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 433. India Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 434. India Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 435. India Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 436. India Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 437. South Korea Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 438. South Korea Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 439. South Korea Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 440. South Korea Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 441. Taiwan Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 442. Taiwan Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 443. Taiwan Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 444. Taiwan Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 445. Australia Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 446. Australia Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 447. Australia Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 448. Australia Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 449. Rest of Asia-Pacific Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 450. Rest of Asia-Pacific Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 451. Rest of Asia-Pacific Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 452. Rest of Asia-Pacific Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 453. Europe Pain Management Drugs Sales, by Country K Unit (2021-2026)
  • Table 454. Europe Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 455. Europe Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 456. Europe Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 457. Europe Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 458. Germany Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 459. Germany Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 460. Germany Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 461. Germany Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 462. France Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 463. France Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 464. France Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 465. France Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 466. Italy Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 467. Italy Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 468. Italy Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 469. Italy Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 470. United Kingdom Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 471. United Kingdom Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 472. United Kingdom Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 473. United Kingdom Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 474. Netherlands Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 475. Netherlands Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 476. Netherlands Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 477. Netherlands Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 478. Rest of Europe Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 479. Rest of Europe Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 480. Rest of Europe Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 481. Rest of Europe Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 482. MEA Pain Management Drugs Sales, by Country K Unit (2021-2026)
  • Table 483. MEA Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 484. MEA Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 485. MEA Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 486. MEA Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 487. Middle East Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 488. Middle East Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 489. Middle East Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 490. Middle East Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 491. Africa Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 492. Africa Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 493. Africa Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 494. Africa Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 495. North America Pain Management Drugs Sales, by Country K Unit (2021-2026)
  • Table 496. North America Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 497. North America Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 498. North America Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 499. North America Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 500. United States Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 501. United States Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 502. United States Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 503. United States Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 504. Canada Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 505. Canada Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 506. Canada Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 507. Canada Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 508. Mexico Pain Management Drugs Sales, by Type K Unit (2021-2026)
  • Table 509. Mexico Pain Management Drugs Sales, by Application K Unit (2021-2026)
  • Table 510. Mexico Pain Management Drugs Sales, by Distribution Channel K Unit (2021-2026)
  • Table 511. Mexico Pain Management Drugs Sales, by Drug Class K Unit (2021-2026)
  • Table 512. Pain Management Drugs: by Type(USD/Units)
  • Table 513. Research Programs/Design for This Report
  • Table 514. Key Data Information from Secondary Sources
  • Table 515. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pain Management Drugs: by Type USD Million (2015-2020)
  • Figure 5. Global Pain Management Drugs: by Application USD Million (2015-2020)
  • Figure 6. Global Pain Management Drugs: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America Pain Management Drugs Share (%), by Country
  • Figure 8. Asia Pacific Pain Management Drugs Share (%), by Country
  • Figure 9. Europe Pain Management Drugs Share (%), by Country
  • Figure 10. MEA Pain Management Drugs Share (%), by Country
  • Figure 11. North America Pain Management Drugs Share (%), by Country
  • Figure 12. Global Pain Management Drugs: by Type K Unit (2015-2020)
  • Figure 13. Global Pain Management Drugs: by Application K Unit (2015-2020)
  • Figure 14. Global Pain Management Drugs: by Distribution Channel K Unit (2015-2020)
  • Figure 15. South America Pain Management Drugs Share (%), by Country
  • Figure 16. Asia Pacific Pain Management Drugs Share (%), by Country
  • Figure 17. Europe Pain Management Drugs Share (%), by Country
  • Figure 18. MEA Pain Management Drugs Share (%), by Country
  • Figure 19. North America Pain Management Drugs Share (%), by Country
  • Figure 20. Global Pain Management Drugs: by Type USD/Units (2015-2020)
  • Figure 21. Global Pain Management Drugs share by Players 2020 (%)
  • Figure 22. Global Pain Management Drugs share by Players (Top 3) 2020(%)
  • Figure 23. Global Pain Management Drugs share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer (United States) Revenue: by Geography 2020
  • Figure 27. GSK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. GSK (United Kingdom) Revenue: by Geography 2020
  • Figure 29. Grunenthal (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Grunenthal (Germany) Revenue: by Geography 2020
  • Figure 31. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Bayer (Germany) Revenue: by Geography 2020
  • Figure 33. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 34. Sanofi (France) Revenue: by Geography 2020
  • Figure 35. Eli Lilly (United States) Revenue, Net Income and Gross profit
  • Figure 36. Eli Lilly (United States) Revenue: by Geography 2020
  • Figure 37. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. AstraZeneca (United Kingdom) Revenue: by Geography 2020
  • Figure 39. Endo (Ireland) Revenue, Net Income and Gross profit
  • Figure 40. Endo (Ireland) Revenue: by Geography 2020
  • Figure 41. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 42. Merck (United States) Revenue: by Geography 2020
  • Figure 43. Depomed (United States) Revenue, Net Income and Gross profit
  • Figure 44. Depomed (United States) Revenue: by Geography 2020
  • Figure 45. Global Pain Management Drugs: by Type USD Million (2021-2026)
  • Figure 46. Global Pain Management Drugs: by Application USD Million (2021-2026)
  • Figure 47. Global Pain Management Drugs: by Distribution Channel USD Million (2021-2026)
  • Figure 48. South America Pain Management Drugs Share (%), by Country
  • Figure 49. Asia Pacific Pain Management Drugs Share (%), by Country
  • Figure 50. Europe Pain Management Drugs Share (%), by Country
  • Figure 51. MEA Pain Management Drugs Share (%), by Country
  • Figure 52. North America Pain Management Drugs Share (%), by Country
  • Figure 53. Global Pain Management Drugs: by Type K Unit (2021-2026)
  • Figure 54. Global Pain Management Drugs: by Application K Unit (2021-2026)
  • Figure 55. Global Pain Management Drugs: by Distribution Channel K Unit (2021-2026)
  • Figure 56. South America Pain Management Drugs Share (%), by Country
  • Figure 57. Asia Pacific Pain Management Drugs Share (%), by Country
  • Figure 58. Europe Pain Management Drugs Share (%), by Country
  • Figure 59. MEA Pain Management Drugs Share (%), by Country
  • Figure 60. North America Pain Management Drugs Share (%), by Country
  • Figure 61. Global Pain Management Drugs: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Pfizer (United States)
  • GSK (United Kingdom)
  • Grunenthal (Germany)
  • Bayer (Germany)
  • Sanofi (France)
  • Eli Lilly (United States)
  • AstraZeneca (United Kingdom)
  • Endo (Ireland)
  • Merck (United States)
  • Depomed (United States)
Additional players considered in the study are as follows:
Yunnan Baiyao , Teva , J&J , Allergan , Purdue
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation